I do believe that with good combo results we will see a rise in share price. We need sustainable momentum and partnership money will give us that. I think the market is in fear mode with companies like Novavax collapsing every other day on bad news. Holding tight and still believe in Oncosec. GLTA!
Just have a quick question. In ONCOSEC presentation, on slide # 3 it states "Encouraging clinical data (response rates: 64-75%) in long -term, follow-up trial where patients received anti-PD-1/PD-L1 after ImmunoPulse®IL-12. Which cancer did they do the trial? The # of patients involved? Have they presented anywhere or did any PR?